Biotech raises $42 million to run Huntington’s disease trial Latus Bio plans to seek FDA permission to start the clinical trial in the next few months

https://www.statnews.com/2026/05/04/biotech-startup-latus-bio-raises-42-million-run-huntingtons-trial/ By Allison DeAngelisMay 4, 2026 Biotech Startups and Venture Capital Reporter